Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
– LINZESS® (linaclotide) EUTRx demand growth of 11% for full year 2025 year-over-year – – 2025 Ironwood revenue of $296 million, GAAP net income of $24 million... Read more.
Lumen Marks New Phase of Transformation at 2026 Investor Day
Declares completion of turnaround and outlines multi-year growth plan Updates key initiatives supporting company’s position as the trusted network for AI, including... Read more.
Alkermes plc Announces CEO Succession Plan
— Richard Pops to Retire from Role of Chief Executive Officer Following Distinguished 35-year Career with Alkermes — — Board of Directors Appointed Blair Jackson,... Read more.
UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
–(BUSINESS WIRE)–The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March... Read more.
Blackstone Secured Lending Fund Reports Fourth Quarter and Full-Year 2025 Results
NEW YORK–(BUSINESS WIRE)–Blackstone Secured Lending Fund (NYSE: BXSL or the “Company”) today reported its fourth quarter and full-year 2025 results.... Read more.
Broadstone Net Lease Announces Two Additional Build-to-Suit Developments for $62.1 million
VICTOR, N.Y.–(BUSINESS WIRE)–#acquisitions–Broadstone Net Lease, Inc. (NYSE: BNL) (“BNL”, the “Company”, “we”, “our”, or “us”),... Read more.
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today... Read more.
Chatham Lodging Announces Fourth Quarter 2025 Results
WEST PALM BEACH, Fla.–(BUSINESS WIRE)–Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay... Read more.
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
HENDERSON, Nev.–(BUSINESS WIRE)–$ZURA #TeamZura–Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated... Read more.
Don Hawk Joins the Board of Life Science Connect to Drive Data Insights and Connections
PITTSBURGH–(BUSINESS WIRE)–Life Science Connect (“LSC”) is pleased to announce the appointment of Don Hawk to its Board of Directors. LSC is a portfolio... Read more.